The antioxidant alpha-lipoic acid improves endothelial dysfunction induced by acute hyperglycaemia during OGTT in impaired glucose tolerance

Clinical Endocrinology

Volumn 68, Issue 5, 2008, Pages 716-723

  Xiang, Guang Da ^a   Sun, Hui Ling ^a   Zhao, Lin Shuang ^a   Hou, Jie ^a   Yue, Ling ^a   Xu, Lin ^a  

^a WUHAN GENERAL HOSPITAL OF GUANGZHOU COMMAND   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA LIPON 300; ANTIOXIDANT; C REACTIVE PROTEIN; GLUCOSE; GLYCERYL TRINITRATE; LIPOPROTEIN A; LOW DENSITY LIPOPROTEIN CHOLESTEROL; OXYGEN RADICAL; SODIUM CHLORIDE; THIOBARBITURIC ACID REACTIVE SUBSTANCE; THIOCTIC ACID; UNCLASSIFIED DRUG;

ADULT; ARTERY DILATATION; ARTICLE; ATHEROSCLEROSIS; CARDIOVASCULAR DISEASE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED STUDY; DIET RESTRICTION; DOUBLE BLIND PROCEDURE; ENDOTHELIAL DYSFUNCTION; FEMALE; GLUCOSE BLOOD LEVEL; HUMAN; HYPERGLYCEMIA; IMPAIRED GLUCOSE TOLERANCE; MALE; MULTIPLE REGRESSION; NON INSULIN DEPENDENT DIABETES MELLITUS; ORAL GLUCOSE TOLERANCE TEST; PRIORITY JOURNAL; TREATMENT OUTCOME; ULTRASOUND; VASCULAR ENDOTHELIUM;

ADULT; ANTIOXIDANTS; BLOOD GLUCOSE; CASE-CONTROL STUDIES; ENDOTHELIUM, VASCULAR; FEMALE; FREE RADICALS; GLUCOSE TOLERANCE TEST; HUMANS; HYPERGLYCEMIA; MALE; MIDDLE AGED; THIOCTIC ACID;

EID: 42149171377     PISSN: 03000664     EISSN: 13652265     Source Type: Journal    
DOI: 10.1111/j.1365-2265.2007.03099.x     Document Type: Article

References (36)

1. Mykkänen, L., Laakso, M. Pyörälä, K. (1992) Asymptomatic hyperglycemia and atherosclerosic vascular disease in the elderly. Diabetes Care, 15, 1020 1030.
2. Wingard, D.L., Barrett-Connor, E.L., Scheidt-Nave, C. McPhillips, J.B. (1993) Prevalence of cardiovascular and renal complications in older adults with normal or impaired glucose tolerance or NIDDM. Diabetes Care, 16, 1022 1025.
3. Boneti, P.O., Lerman, L.O. Lerman, A. (2003) Endothelial dysfunction, a marker of atherosclerotic risk. Arteriosclerosis, Thrombosis and Vascular Biology, 23, 168 175.
4. Schaechinger, V., Britten, M.B. Zeiher, A.M. (2000) Prognostic impact of coronary vasodilator dysfunction on adverse long-term outcome of coronary heart disease. Circulation, 101, 1899 1906.
5. Hink, U., Li, H., Mollnau, H., Oelze, M., Matheis, E., Hartmann, M., Skatchkov, M., Thaiss, F., Stahl, R.A., Warnholtz, A., Meinertz, T., Griendling, K., Harrison, D.G., Forstemann, U. Munzel, T. (2001) Mechanisms underlying endothelial dysfunction in diabetes mellitus. Circulation Research, 88, 14 22.
6. Kawano, H., Motoyama, T., Hirashima, O., Nobutaka, H., Miyao, Y., Salamoto, T., Kugiyama, K., Ogawa, H. Yasue, H. (1999) Hyperglycemia rapidly suppresses flow-mediated endothelium-dependent vasodilation of brachial artery. Journal of the American College of Cardiology, 34, 146 154.
7. Schmoelzer, I. Wascher, T.C. (2006) Effect of repaglinide on endothelial dysfunction during a glucose tolerance test in subjects with impaired glucose tolerance. Cardiovascular Diabetology, 5, 9 12.
8. Wascher, T.C., Schmoelzer, I., Wiegratz, A., Stuehlinger, M., Mueller-Wieland, D., Kotzka, J. Enderle, M. (2005) Reduction of postchallenge hyperglycaemia prevents acute endothelial dysfunction in subjects with impaired glucose tolerance. European Journal of Clinical Investigation, 35, 551 557.
9. Nagamastsu, M., Nickander, K.K., Schmelzer, J.D., Ray, A., Wittrock, D.A., Tritschler, H. Low, P.A. (1995) Lipoic acid improves nerve blood flow, reduces oxidative stress, and improves distal nerve conduction in experimental diabetic neuropathy. Diabetes Care, 18, 1160 1167.
10. Packer, L., Witt, E.H. Tritschler, H.-J. (1995) Antioxidant properties and clinical applications of alpha-lipoic acid and dihydrolipoic acid. In : E. Cadenas, L. Packer eds. Handbook of Antioxidants. Marcel Dekker, New York, 545 591.
11. Motoyama, T., Kawano, H., Kugiyama, K., Hirashima, O., Ohgushi, M., Tsunoda, R., Moriyama, Y., Miyao, Y., Yoshimura, M., Ogawa, H. Yasue, H. (1998) Vitamin E administration improves impairment of endothelium-dependent vasodilation in patients with coronary spastic angina. Journal of the American College of Cardiology, 32, 1672 1679.
12. Buege, J.A. Aust, S.D. (1987) Microsomal lipid peroxidation. Methods in Enzymology, 52, 302 310.
13. Xiang, G.D. Wu, Y.H. (2003) Apolipoprotein e4 allele and endothelium-dependent arterial dilation in type 2 diabetes mellitus without angiopathy. Diabetologia, 46, 514 519.
14. Xiang, G.D. Wang, Y.L. (2004) Regular aerobic exercise training improves endothelium-dependent artery dilation in patients with impaired fasting glucose. Diabetes Care, 27, 801 802.
15. Xiang, G.D., Xu, L., Zhao, L.S., Yue, L. Hou, J. (2006) The relationship between plasma osteoprotegerin and endothelium-dependent arterial dilation in type 2 diabetes. Diabetes, 55, 2126 2131.
16. Tominaga, M., Eguchi, H., Igarashi, K., Kato, T. Sekikawa, A. (1999) Impaired glucose tolerance is a risk factor for cardiovascular disease, but not impaired fasting glucose: the Funagata Diabetes Study. Diabetes Care, 22, 920 924.
17. Kuller, L.H., Velentgas, P., Barzilay, J., Beauchanp, N.J., Oleary, D.H. Savage, P.J. (2000) Diabetes mellitus: subclinical cardiovascular disease and risk of incident cardiovascular disease and all-cause mortality. Arteriosclerosis, Thrombosis and Vascular Biology, 20, 823 829.
18. The DECODE study: Group for the European Diabetes Epidemiology Group (2001) Glucose tolerance and cardiovascular mortality: comparison of fasting and two hour diagnostic criteria. Archives of Internal Medicine, 161, 397 405.
19. Vital, J.A. Keaney, J.F. (2002) Endothelial function: a barometer for cardiovascular risk. Circulation, 106, 640 642.
20. Widlansky, M.E., Gocke, N., Keaney, J.F. Vita, J.A. (2003) The clinical implications of endothelial dysfunction. Journal of the American College of Cardiology, 42, 1149 1160.
21. Leurs, P.B., Oerle, R.V., Stolk, R.P., Grobbee, D.E., Hamulyak, K. Wolffenbuttel, B.H.R. (2002) Tissue factor pathway inhibitor and other endothelium-dependent hemostatic factors in elderly individuals with normal or impaired glucose tolerance and type 2 diabetes. Diabetes Care, 25, 1340 1345.
22. Nathan, D.M., Meigs, J.B. Singer, D.E. (1997) The epidemiology of cardiovascular disease in type 2 diabetes mellitus: how sweet it is or is it? Lancet, 350, SI4 S19.
23. Meigs, J.B., Singer, D.E., Sullivan, L.M., Dukes, KA, D'Agostino, R.B., Nathan, D.M., Wager, E.H., Kaplan, S.H. Greenfield, S. (1997) Metabolic control and prevalent cardiovascular disease in non-insulin-dependent diabetes mellitus (NIDDM). The NIDDM Patients Outcome Research Team. American Journal of Medicine, 102, 38 47.
24. Moncada, S., Palmer, R.M.J. Higgs, E.A. (1991) Nitric oxide: physiology, pathophysiology, and pharmacology. Pharmacological Reviews, 43, 109 142.
25. Gryglewski, R.J., Palmer, R.M.J. Moncada, S. (1986) Superoxide anion is involved in the breakdown of endothelium-dependent vascular relaxing factor. Nature, 320, 454 456.
26. Rubanyi, G.M. Vanhoutte, P.M. (1986) Oxygen-derived free radicals, endothelium, and responsiveness of vascular smooth muscle. American Journal of Physiology, 250, H815 H821.
27. Paolisso, G., Tagliamonte, M.R., Barbieri, M., Zito, G.A., Gambardella, A., Varricchio, G., Ragno, E. Varricchio, M. (2000) Chronic vitamin E administration improves brachial reactivity and increases intracellular magnesium concentration in type II diabetic patients. Journal of Clinical Endocrinology and Metabolism, 85, 109 115.
28. Title, L.M., Cummings, P.M., Giddens, K. Nassar, B.A. (2000) Oral glucose loading acutely attenuates endothelium-dependent vasodilation in healthy adults without diabetes: an effect prevented by vitamin C and E. Journal of the American College of Cardiology, 36, 2185 2191.
29. 10 in health and disease. European Journal of Clinical Nutrition, 53, 764 770.
30. Thomas, S.R., Witting, P.K. Stocker, R. (1999) A role for reduced coenzyme Q in atherosclerosis? Biofactors, 9, 207 224.
31. 10 improves endothelial dysfunction of the brachial artery in type II diabetes mellitus. Diabetologia, 45, 420 426.
32. Reed, L.J. (1998) From lipoic acid to multi-enzyme complexes. Protein Science, 7, 220 224.
33. Ziegler, D., Nowak, H., Kempler, P., Vargha, P. Low, P.A. (2004) Treatment of symptomatic diabetic polyneuropathy with the antioxidant alpha-lipoic acid: a meta-analysis. Diabetic Medicine, 21, 114 121.
34. Beckman, J.S. Koppenol, W.H. (1996) Nitric oxide, superoxide, and peroxynitrite: the good, the bad, and the ugly. American Journal of Physiology, 271, C1424 C1437.
35. Tesfamariam, B. Cohen, R.A. (1992) Free radicals mediate endothelial cell dysfunction caused by elevated glucose. American Journal of Physiology, 263, H321 H326.
36. Hsueh, W.A. Quinones, M.J. (2003) Role of endothelial dysfunction in insulin resistance. American Journal of Cardiology, 92, 10 71.